Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, SEP 7: NCI Clinical and Translational Exploratory/Developmental Studies.                    

*Date:*                         February 16, 2018.                    

*Time:*                         7:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.                    

*Contact Person:*                         Robert S. Coyne, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W236, Bethesda, MD 20892-9750, 240-276-5120,                         *coyners@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, TEP-7A: Cancer Symptom Management.                    

*Date:*                         February 21, 2018.                    

*Time:*                         10:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 1E030, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Jeffrey E. DeClue, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W114, Bethesda, MD 20892-9750, 240-276-6371,                         *decluej@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, TEP-7B: Models for Disparity Research.                    

*Date:*                         February 22, 2018.                    

*Time:*                         12:00 p.m. to 3:00 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 1E030, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Jeffrey E. DeClue, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W114, Bethesda, MD 20892-9750, 240-276-6371,                         *decluej@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Physical Science—Oncology Projects.                    

*Date:*                         February 23, 2018.                    

*Time:*                         12:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W242, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Zhiqiang Zou, MD, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W242, Bethesda, MD 20892-9750, 240-276-6372,                         *zouzhiq@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Initial Review Group, Subcommittee J—Career Development.                    

*Date:*                         February 28-March 1, 2018.                    

*Time:*                         8:00 a.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.                    

*Contact Person:*                         Tushar Deb, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W624, Bethesda, MD 20892-9750, 240-276-6132,                         *tushar.deb@nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, U01 Conference Grant Review.                    

*Date:*                         February 28, 2018.                    

*Time:*                         1:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W556, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Bratin K. Saha, Ph.D., Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W556, Bethesda, MD 20892-9750, 240-276-6411,                         *sahab@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, Multilevel Interventions in Cancer Care Delivery.                    

*Date:*                         February 28, 2018.                    

*Time:*                         12:30 p.m. to 3:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W104, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Eun Ah Cho, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W104, Bethesda, MD 20892-9750, 240-276-6342,                         *choe@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, NCI Program Project VII (P01) Review.                    

*Date:*                         March 2, 2018.                    

*Time:*                         8:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852.                    

*Contact Person:*                         Clifford W. Schweinfest, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W108, Bethesda, MD 20892-9750, 240-276-6343,                         *schweinfestcw@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, Innovative Molecular and Cellular Analysis Technologies (IMAT).                    

*Date:*                         March 2, 2018.                    

*Time:*                         8:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852.                    

*Contact Person:*                         Yasuko Furumoto, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W424, Bethesda, MD 20892-9750, 240-276-5287,                         *yasuko.furumoto@nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents plus Radiotherapy.                    

*Date:*                         March 2, 2018.                    

*Time:*                         10:00 a.m. to 12:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W640, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Saejeong J. Kim, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W640, Bethesda, MD 20892-9750, 240-276-5179,                         *saejeong.kim@nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, SEP-1B: NCI Clinical and Translational Exploratory/Developmental Studies.                    

*Date:*                         March 2, 2018.                              ( print page 3352)    

*Time:*                         12:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W248, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Anita T. Tandle, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W248, Bethesda, MD 20892-9750, 240-276-5007,                         *tandlea@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, SEP-5B: NCI Clinical and Translational Exploratory/Developmental Studies.                    

*Date:*                         March 7, 2018.                    

*Time:*                         11:00 a.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W264, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Ombretta Salvucci, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W264, Bethesda, MD 20892-9750, 240-276-7286,                         *salvucco@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, Outstanding Investigator Award I.                    

*Date:*                         March 8-9, 2018.                    

*Time:*                         8:00 a.m. to 1:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878.                    

*Contact Person:*                         Caterina Bianco, MD, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W110, Bethesda, MD 20892-9750, 240-276-6459,                         *biancoc@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, U01 Small Cell Lung Cancer Consortium.                    

*Date:*                         March 14, 2018.                    

*Time:*                         12:00 p.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W238, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Byeong-Chel Lee, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W238, Bethesda, MD 20892-9750, 240-276-7755,                         *byeong-chel.lee@nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, Cancer Biomarkers and Biospecimens Review Meeting.                    

*Date:*                         March 22, 2018.                    

*Time:*                         10:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W106, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Reed A. Graves, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W106, Bethesda, MD 20892-9750, 240-276-6384,                         *gravesr@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, Omnibus SEP-6.                    

*Date:*                         April 3-4, 2018.                    

*Time:*                         6:00 p.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852.                    

*Contact Person:*                         Eduardo E. Chufan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W254, Bethesda, MD 20892-9750, 240-276-7975,                         *chufanee@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: January 18, 2018.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2018-01189 Filed 1-23-18; 8:45 am]

 BILLING CODE 4140-01-P